東方中科(002819.SZ)擬註銷西安分公司
格隆匯12月12日丨東方中科(002819.SZ)公佈,2019年12月12日,公司第四屆董事會第十六次會議審議通過了《關於註銷西安分公司的議案》。
北京東方中科集成科技股份有限公司西安分公司由於日常經營原因,特此申請註銷。分公司註銷對公司運營不產生影響,註銷完成後,上述分公司的資產及業務將全部納入公司,其本身不再具有任何資產及業務。為優化企業管理及資源配置,提議註銷上述分公司。
註銷分公司資產及業務將全部納入公司。此次註銷不會對公司整體發展和盈利水平造成影響,將有利於優化公司資產結構,降低管理成本,對提高公司管理運營效率有積極作用。用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.